Print

Neptune Technologies & Bioressources Inc. Subsidiary Acasti Pharma Receives Conditional Approval for Listing on TSX-Venture  
2/28/2011 10:02:32 AM

LAVAL, Quebec, Feb. 28, 2011 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX-V:NTB) and Acasti Pharma ("Acasti"), a Neptune subsidiary, announces that Acasti has received conditional approval for the listing of its class A common shares (the "Class A shares") on the TSX Venture Exchange (the "Exchange") under the ticker symbol APO.
//-->